Download PDF
Pneumologie 2000; 54(10): 468-473
DOI: 10.1055/s-2000-7690
ORIGINALARBEIT AUS DEM ENGLISCHEN
Georg Thieme Verlag Stuttgart · New York

Perforin-positive Lymphozyten im peripheren Blut bei extrinsischem und intrinsischem Asthma[1] , [2]

V. Arnold, S. Balkow, R. Staats, H. Matthys, W. Luttmann, J. C. Virchow Jr.
  • Pneumologische Abteilung der Medizinischen Universitätsklinik Freiburg, Deutschland
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Also available at
   Permissions and Reprints

Zusammenfassung:

Asthma bronchiale geht mit einer chronischen, T-Zell-vermittelten bronchialen Entzündung einher. Die Ursache der Erkrankung ist jedoch bis heute unklar. Ähnlich anderen T-Zell-vermittelten chronisch-entzündlichen Erkrankungen, die mit Autoimmunreaktionen assoziiert sind, gibt es auch einzelne Hinweise für Autoimmunphänomene beim Asthma. Da verschiedene Autoimmunerkrankungen mit der Expression von Perforin, einem zytotoxischen Molekül, das von Lymphozyten gebildet wird, einhergehen, sind wir der Hypothese nachgegangen, ob sich beim allergischen und intrinsischen Asthma vermehrt Perforin-produzierende Lymphozyten nachweisen lassen. Dazu wurde intrazellulär die Perforinexpression peripherer Blutlymphozyten von Patienten mit extrinsischem Asthma (n = 13), intrinsischen Asthma (n = 7) und gesunden Kontrollprobanden (n = 18) verglichen. Mittels Durchflusszytometrie wurden die Gesamtlymphozyten identifiziert und mit Hilfe monoklonaler Antikörper in ihre Subpopulationen CD3+, CD4+, CD8+, CD16+ und CD56+ unterteilt. Der Prozentsatz der Perforin-positiven Gesamtlymphozyten war, verglichen mit gesunden Kontrollprobanden, bei Patienten mit allergischem aber auch beim intrinsischem Asthma signifikant erhöht. Verglichen mit gesunden Kontrollprobanden ergab die Untersuchung der Lymphozytensubpopulationen signifikant höhere Prozentsätze an CD3-, CD4-, CD8- und CD56-positiven Zellen beim intrinsischen Asthma, die gleichzeitig auch Perforin exprimierten. Die Perforinexpression in CD4+-Zellen beim intrinsischen Asthma war sogar im Vergleich zum allergischen Asthma signifikant erhöht. Daraus ist zu schließen, dass das allergische und das intrinsische Asthma mit einem Anstieg der Perforin-Expression in T-Lymphozyten-Subpopulationen einhergehen.

Increase in Perforin-Positive Peripheral Blood Lymphocytes in Extrinsic and Intrinsic Asthma:

The cause of asthma, which has been linked to a chronic, T-cell-mediated bronchial inflammation, remains unclear. A number of other T-lymphocyte-mediated, chronic inflammatory disorders have been associated with autoimmunity and there are data indicating that autoimmune phenomena might also be present in asthma. Expression of perforin, a cytotoxic molecule produced by lymphocytes, has been implicated in the pathogenesis of autoimmune diseases. We therefore tested the hypothesis that allergic and intrinsic asthma might be associated with an increase in lymphocytes producing perforin by comparing the expression of intracellular perforin in peripheral blood lymphocytes of patients with extrinsic asthma (n = 13), intrinsic asthma (n = 7), and healthy control subjects (n = 18). Lymphocytes were identified using flow cytometry and subdivided into CD3(+), CD4(+), CD8(+), CD16(+), and CD56(+) subpopulations after staining with appropriate monoclonal antibodies. The percentage of perforin-positive total lymphocytes was significantly elevated in patients with allergic as well as intrinsic asthma when compared with normal control subjects. Analysis of lymphocyte subpopulations also revealed a significant increase in the percentage of CD3(+), CD4(+), CD8(+), and CD56(+) cells expressing perforin in allergic asthma and a significant increase in the percentage of CD4(+) and CD56(+) cells in intrinsic asthma when compared with healthy control subjects. Perforin expression in CD4(+) cells in intrinsic asthma was also significantly elevated compared with allergic asthma. We conclude that allergic and intrinsic asthma is associated with increased expression of perforin in T-lymphocyte subsets.

1 Deutsche Fassung von: Increase in Perforin-Positive Peripheral Blood Lymphocytes in Extrinsic and Intrinsic Asthma (Am J Respir Crit Care Med 2000; 161: 182 -186)

2 Herrn Prof. Dr. med. Heinrich Matthys zum 65. Geburtstag gewidmet

Literatur

  • 1 Walker C, Bode E, Boer L, Hansel T T, Blaser K, Virchow Jr J C. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage.  Am Rev Respir Dis. 1992;  146 109-115
    PubMedGoogle Scholar
  • 2 Virchow Jr J C, Walker C, Hafner D, Kortsik C, Werner P, Matthys H, Kroegel C. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma.  Am J Respir Crit Care Med. 1995;  151 960-968
    PubMedGoogle Scholar
  • 3 Szczeklik A, Nizankowska E, Serafin A, Dyczek A, Duplaga M, Musial J. Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance.  Am J Respir Crit Care Med. 1995;  152 1753-1756
    PubMedGoogle Scholar
  • 4 Turner-Warwick M, Haslam P. Smooth muscle antibody in bronchial asthma.  Clin Exp Immunol. 1970;  7 31-38
    PubMedGoogle Scholar
  • 5 Egeskjold E M, Permin H, Nielsen I, Sorensen H J, Osterballe O, Kallerup H E. Anti-IgG antibodies and antinuclear antibodies in allergic patients.  European Journal of Allergy & Clinical Immunology. 1981;  36 573-581
    PubMedGoogle Scholar
  • 6 Lidor Y, Topilsky M, Spitzer S A, Yehoshua H. Autoimmune antibodies in intrinsic (non-atopic) asthma.  Annals of Allergy. 1980;  44 296-298
    PubMedGoogle Scholar
  • 7 Menon P, Menon V, Hilman B C, Wolf R, Bairnsfather L. Antinuclear antibodies and anticytoplasmic antibodies in bronchial asthma.  J Allergy Clin Immunol. 1989;  84 937-943
    PubMedGoogle Scholar
  • 8 Venter J C, Fraser C M, Harrison L C. Autoantibodies to beta 2-adrenergic receptors: a possible cause of adrenergic hyporesponsiveness in allergic rhinitis and asthma.  Science. 1980;  207 1361-1363
    PubMedGoogle Scholar
  • 9 Bousquet J, Chanez P, Lacoste J Y, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P. et al . Eosinophilic inflammation in asthma.  New England Journal of Medicine. 1990;  323 1033-1039
    CrossrefPubMedGoogle Scholar
  • 10 Krejsek J, Kral B, Vokurkova D, Derner V, Touskova M, Parakova Z, Kopecky O. Decreased peripheral blood gamma delta T cells in patients with bronchial asthma.  European Journal of Allergy & Clinical Immunology. 1998;  53 73-77
    PubMedGoogle Scholar
  • 11 Lichtenheld M G, Olsen K J, Lu P, Lowrey D M, Hameed A, Hengartner H, Podack E R. Structure and function of human perforin.  Nature. 1988;  335 448-451
    CrossrefPubMedGoogle Scholar
  • 12 Millard P J, Henkart M P, Reynolds C W, Henkart P A. Purification and properties of cytoplasmic granules from cytotoxic rat LGL tumors.  J Immunol. 1984;  132 3197-3204
    PubMedGoogle Scholar
  • 13 Shinkai Y, Takio K, Okumura K. Homology of perforin to the ninth component of complement (C9).  Nature. 1988;  334 525-527
    CrossrefPubMedGoogle Scholar
  • 14 Koizumi H, Liu C C, Zheng L M, Joag S V, Bayne N K, Holoshitz J, Young J D. Expression of perforin and serine esterases by human gamma/delta T cells.  J Exp Med. 1991;  173 499-502
    CrossrefPubMedGoogle Scholar
  • 15 Konjevic G, Schlesinger B, Cheng L, Olsen K J, Podack E R, Spuzic I. Analysis of perforin expression in human peripheral blood lymphocytes, CD56+ natural killer cell subsets and its induction by interleukin-2.  Immunol Invest. 1995;  24 499-507
    PubMedGoogle Scholar
  • 16 Nakata M, Kawasaki A, Azuma M, Tsuji K, Matsuda H, Shinkai Y, Yagita H, Okumura K. Expression of perforin and cytolytic potential of human peripheral blood lymphocyte subpopulations.  Int Immunol. 1992;  4 1049-1054
    PubMedGoogle Scholar
  • 17 Rubesa G, Podack E R, Sepcic J, Rukavina D. Increased perforin expression in multiple sclerosis patients during exacerbation of disease in peripheral blood lymphocytes.  J Neuroimmunol. 1997;  74 198-204
    CrossrefPubMedGoogle Scholar
  • 18 Matusevicius D, Kivisakk P, Navikas V, Soderstrom M, Fredrikson S, Link H. Interleukin-12 and perforin mRNA expression is augmented in blood mononuclear cells in multiple sclerosis.  Scand J Immunol. 1998;  47 582-590
    CrossrefPubMedGoogle Scholar
  • 19 Seko Y, Minota S, Kawasaki A, Shinkai Y, Maeda K, Yagita H, Okumura K, Sato O, Takagi A, Tada Y. et al . Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu's arteritis.  J Clin Invest. 1994;  93 750-758
    CrossrefPubMedGoogle Scholar
  • 20 Wu Z, Podack E R, McKenzie J M, Olsen K J, Zakarija M. Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease.  Clin Exp Immunol. 1994;  98 470-477
    PubMedGoogle Scholar
  • 21 Darmon A J, Nicholson D W, Bleackley R C. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B.  Nature. 1995;  377 446-448
    CrossrefPubMedGoogle Scholar
  • 22 Darmon A J, Ley T J, Nicholson D W, Bleackley R C. Cleavage of CPP32 by granzyme B represents a critical role for granzyme B in the induction of target cell DNA fragmentation.  J Biol Chem. 1996;  271 21709-21712
    CrossrefPubMedGoogle Scholar
  • 23 Spaner D, Raju K, Radvanyi L, Lin Y, Miller R G. A role for perforin in activation-induced cell death.  J Immunol. 1998;  160 2655-2664
    PubMedGoogle Scholar
  • 24 Topham D J, Tripp R A, Doherty P C. CD8+ T cells clear influenza virus by perforin of Fas-dependent processes.  J Immunol. 1997;  159 5197-5200
    PubMedGoogle Scholar
  • 25 Sambhara S, Switzer I, Kurichh A, Miranda R, Urbanczyk L, James O, Underdown B, Klein M, Burt D. Enhanced antibody and cytokine responses to influenza viral antigens in perforin-deficient mice.  Cellular Immunology. 1998;  187 13-18
    CrossrefPubMedGoogle Scholar
  • 26 Virchow Jr J C, Kroegel C, Walker C, Matthys H. Inflammatory determinants of asthma severity: mediator and cellular changes in bronchoalveolar lavage fluid of patients with severe asthma.  J Allergy Clin Immunol. 1996;  98 S27-33
    PubMedGoogle Scholar
  • 27 Anonymous . International consensus report on diagnosis and treatment of asthma.  European Respiratory Journal. 1992;  5 601-641
    PubMedGoogle Scholar
  • 28 Luttmann W, Herzog V, Virchow Jr J C, Matthys H, Thierauch K H, Kroegel C. Prostacyclin modulates granulocyte/macrophage colony-stimulating factor release by human blood mononuclear cells.  Pulm Pharmacol. 1996;  9 43-48
    PubMedGoogle Scholar
  • 29 Leung D Y. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases.  J Allergy Clin Immunol. 1995;  96 302-318
    PubMedGoogle Scholar
  • 30 Virchow C. Intrinsic asthma; symptoms, IgE serum levels, pathophysiology.  Prax Pneumol. 1973;  27 578-591
    PubMedGoogle Scholar
  • 31 Rukavina D, Laskarin G, Rubesa G, Strbo N, Bedenicki I, Manestar D, Glavas M, Christmas S E, Podack E R. Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells.  Blood. 1998;  92 2410-2420
    PubMedGoogle Scholar
  • 32 Rutella S, Rumi C, Lucia M B, Etuk B, Cauda R, Leone G. Flow cytometric detection of perforin in normal human lymphocyte subpopulations defined by expression of activation/differentiation antigens.  Immunology Letters. 1998;  60 51-55
    CrossrefPubMedGoogle Scholar
  • 33 Watanabe N, De Rosa C C, Cmelak A, Hoppe R, Herzenberg L A, Roederer M. Long-term depletion of naive T cells in patients treated for Hodgkin's disease.  Blood. 1997;  90 3662-3672
    PubMedGoogle Scholar
  • 34 Vergelli M, Hemmer B, Muraro P A, Tranquill L, Biddison W E, Sarin A, McFarland H F, Martin R. Human autoreactive CD4+ T cell clones use perforin - or Fas/Fas ligand-mediated pathways for target cell lysis.  J Immunol. 1997;  158 2756-2761
    PubMedGoogle Scholar
  • 35 Muller S, Lory J, Corazza N, Griffiths G M, Z'graggen K, Mazzucchelli L, Kappeler A, Mueller C. Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease.  Am J Pathol. 1998;  152 261-268
    PubMedGoogle Scholar
  • 36 Truica C I, Hansen C H, Garvin D F, Meehan K R. Idiopathic giant cell myocarditis after autologous hematopoietic stem cell transplantation and interleukin-2 immunotherapy: a case report.  Cancer. 1998;  83 1231-1236
    CrossrefPubMedGoogle Scholar
  • 37 Rafi A Q, Zeytun A, Bradley M J, Sponenberg D P, Grayson R L, Nagarkatti M, Nagarkatti P S. Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome.  J Immunol. 1998;  161 3077-3086
    PubMedGoogle Scholar
  • 38 Peng S L, Moslehi J, Robert M E, Craft J. Perforin protects against autoimmunity in lupus-prone mice.  J Immunol. 1998;  160 652-660
    PubMedGoogle Scholar

1 Deutsche Fassung von: Increase in Perforin-Positive Peripheral Blood Lymphocytes in Extrinsic and Intrinsic Asthma (Am J Respir Crit Care Med 2000; 161: 182 -186)

2 Herrn Prof. Dr. med. Heinrich Matthys zum 65. Geburtstag gewidmet

PD Dr J C Virchow

Abteilung Pneumologie Medizinische Universitätsklinik

Hugstetter Str. 55 79106 Freiburg

Email: E-mail: virchow@med1.ukl.uni-freiburg.de

      >